Karlis Trusinskis

EDUCATION AND TRAINING

• GCP Certificate 14th of October, 2021

• MD, Latvian Academy of Medicine, Riga, Latvia 1991-1997

• Cardiologist, University of Latvia, 1997-2002

• Postgraduate studies:

• • Echocardiography, Monash Medical Centre, Melburne, Australia, 2000

  • Interventional Cardiology, San Donato Hospital, Milan, Italy 2002

  • Interventional Cardiology, Glenfield University Hospital, Leicester, UK, 2003

  • Interventional Cardiology, Catharina Hospital, Eindhoven, Netherlands 2005

• PhD studies, University of Latvia 2007-2010

PROFESSIONAL EXPERIENCE

• Research Institute of Cardiology, University of Latvia: Researcher, 2000-present

• Pauls Stradins Clinical University Hospital, Latvian Centre of Cardiology, Riga , Latvia:

• • Resident, Cardiology                                                       1997-2002

  • Cardiologist                                                                     2002-present

  • Cardiology Early Rehabilitation                                       2004-2006

  • Coronary Care Unit                                                          2006-2008

  • Interventional Cardiologist,                                              2004-present

  • Cardiologists Consultant                                                   2004-present

•   Riga Stradins University: Associate Professor 2015-2024

•  University of Latvia: Associate Professor   2024- present

PROFESSIONAL MEDICAL ASSOCIATIONS

•  President of Latvian Society of Hypertension and Atherosclerosis

• Fellow of European Society of Cardiology (FESC)

• Member of European Society of Hypertension

• Member of European Society of Atherosclerosis

• Member of Latvian Society of Physicians

• Board Member of Latvian Society of Cardiology

• International Associate Member of American College of Cardiology

RESEARCH/ PARTICIPATION IN TRIALS

Lead Investigator, The role of clonal hematopoiesis of indeterminate potential as a potential driver of cardiovascular diseases and its association with clinical outcome. Government FLPP

Fundamental and applied research projects; lzp-2021/1-0293; Riga Stradins University; 2022-2024

Principal Investigator, Early treatment of heart failure: a non-interventional observational study program of patients with heart failure and initiated on dapagliflozin (EVOLUTION-HF) NCT05465213, 2022

Principal Investigator, Global SYMPLICITY Registry (GSR) DEFINE. NCT01534299, 2022-2023

Principal Investigator, Coronary Artery Disease Progression in Patients With Prediabetes. NCT02744976, 2016-2022

Investigator, Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome. (iStrategy) NCT05006183, 2021-2024

Investigator, A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction. (PiCSO-AMI-V) NCT04958421, 2021-2022